FDA wraps up Gilenya safety review; GSK nabs control of Cellzome for $98M;

 @FiercePharma: Italy's Rovati family finds partners with cash: Rottapharm sells 50% stake to private equity firms--BloombergStory | Follow @FiercePharma

> The FDA wrapped up its safety review of Novartis' ($NVS) multiple sclerosis drug Gilenya, concluding that certain patients with cardiovascular problems should avoid using it. Report

> GlaxoSmithKline ($GSK) paid $98 million to take full control of Cellzome, a biotech with expertise in inflammatory diseases. Article

> An official of the EU's top court said it should not adjust AstraZeneca's ($AZN) antitrust fine, levied in connection with patent strategies that held off generic competition for its Prilosec drug. Story

> GlaxoSmithKline defended its tax-payment record in the U.K. in the wake of a BBC report questioning a tax-saving setup in Luxembourg. Item

> A Takeda Pharmaceuticals dealmaker described her plans for scouting M&A prospects in the near term. News

> Hospira ($HSP) recalled one lot of injectable painkillers after discovering that vials may contain too much of the drug. More

> Scotland's cost-effectiveness watchdog recommended against Bristol-Myers Squibb's ($BMY) melanoma treatment Yervoy. Report

Biotech News

 @FierceBiotech: Mobile apps could rival pharma's crown jewels. More | Follow @FierceBiotech

 @RyanMFierce: Interesting case for why mobile health apps could compete with drugs and hurt pharma by @chasedaveAnalysis | Follow @RyanMFierce

 @JohnCFierce: New chief takes helm at Promedior (fibrosis) and steers a course for Boston. More | Follow @JohnCFierce

> First wave of AstraZeneca's CNS R&D group gets the ax. Story

> Newron soars on positive PhIII results, $26M pact for Parkinson's drug. Article

> Buzz: Big Pharma suitors line up for a look at Amylin's books. News

Medical Device News

 @FierceMedDev: Folks, the clock is ticking. Get your nominations in for the 15 fiercest device developers. Survey | Follow @FierceMedDev

> Sonitus Medical lands $25 million Series D round for hearing device. More

> After quiet Q4, device recalls surge in 2012. News

> Boston Sci, Abbott gain European sign-off for stent products & services. Story

Pharma Manufacturing News

> U.K. pharmacy group wants drug exports stopped. Story

> Merck KGaA says cuts will save $385 million. News

> Pakistan's ephedrine scandal takes on international intrigue. Article

Biotech Research News

> Scientist uses stem cells to rebuild bone. News

> How do you make a deaf mouse hear? Emory University tries gene therapy. More

> Compounds may combat cancers by reversing p53 mutation. Article

And Finally... How can genetic sequencing be incorporated in day-to-day patient care? Story

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.